Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
309
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

Collin K. China Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-2819-4041View further author information
ORCID Icon,
Maria A. Rodrigueza Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Yun Qingb Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Lei Fengb Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Felipe Samaniegoa Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Preetesh Jaina Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Mansoor Noorania Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Nathan H. Fowlera Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-9494-1877View further author information
ORCID Icon,
Luis E. Fayada Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jason R. Westina Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sattva S. Neelapua Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Frederick B. Hagemeistera Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Christopher R. Flowersa Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Loretta J. Nastoupila Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 2985-2989 | Received 19 Jun 2020, Accepted 25 Jun 2020, Published online: 06 Jul 2020

References

  • Wang Y, Link BK, Witzig TE, et al. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma. Blood. 2019;134(16):1289–1297.
  • Madsen C, Pedersen MB, Vase MO, et al. Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Ann Oncol. 2015;26(2):393–399.
  • Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL, et al. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol. 2013;163(4):487–495.
  • Alonso-Alvarez S, Magnano L, Alcoceba M, et al. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group. Br J Haematol. 2017;178(5):699–708.
  • Gleeson M, Hawkes EA, Peckitt C, et al. Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013. Leuk Lymphoma. 2017;58(8):1805–1813.
  • Salles G, Seymour JF, Offner F, et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet. 2011;377(9759):42–51.
  • Lugtenburg EJ, Brown P, Holt B, et al. Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study. JCO. 2019;37(15_suppl):7507–7507.
  • Zhou X, Ma T, Zhang Y, et al. Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: a meta-analysis. PLOS One. 2017;12(3):e0174648
  • Uryu H, Mishima Y, Yokoyama M, et al. Efficacy of rituximab maintenance for diffuse large B cell lymphoma with transformation. Blood. 2018;132(Supplement 1):4229–4229.
  • Kansara R, Connors JM, Savage KJ, et al. Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas. Haematologica. 2016;101(10):e411–e4.
  • Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993;82(8):2289–2295.
  • Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6(1):130–140.
  • Fitzgibbon J, Iqbal S, Davies A, et al. Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia. 2007;21(7):1514–1520.
  • Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 2003;101(8):3109–3117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.